Mutant genes related to gallbladder cancer and application of mutant genes
The invention provides a group of mutant genes related to gallbladder cancer and application thereof. The mutant gene related to the gallbladder carcinoma comprises one or more of TP53, ABCC4, AMPD1, ACHE, OXCT1, AGL, BRCA1, MEMO1, WNK1 and ALDH1L1. The mutant gene related to the gallbladder carcino...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
11.11.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention provides a group of mutant genes related to gallbladder cancer and application thereof. The mutant gene related to the gallbladder carcinoma comprises one or more of TP53, ABCC4, AMPD1, ACHE, OXCT1, AGL, BRCA1, MEMO1, WNK1 and ALDH1L1. The mutant gene related to the gallbladder carcinoma comprises one or more of TP53, ABCC4, AMPD1, ACHE, OXCT1, AGL, BRCA1, MEMO1, WNK1 and ALDH1L1. Whole exon sequencing (WES) is carried out through an established early generation human tumor xenotransplantation (PDX) model and primary tumor tissue, gallbladder cancer related mutant genes including TP53, ABCC4, AMPD1, ACHE, OXCT1, AGL, BRCA1, MEMO1, WNK1 and ALDH1L1 and mutation types are screened and identified, the gallbladder cancer related mutant genes can be used as potential action targets for gallbladder cancer treatment, a basis is provided for preparation of drugs for treating gallbladder cancer, and meanwhile, the gallbladder cancer related mutant genes can be used for preparing drugs for treating gallbl |
---|---|
Bibliography: | Application Number: CN202111023026 |